Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study

被引：0
|
作者：
Glauce Cordeiro Ulhôa Tostes
Maria Rosário Cunha
Rosa Tsumeshiro Fukui
Márcia Regina Silva Correia
Dalva Marreiro Rocha
Rosa Ferreira dos Santos
Maria Elizabeth Rossi da Silva
机构：
[1] Universidade de São Paulo,Laboratório de Carboidratos e Radioimunoensaios LIM
来源：
Diabetology & Metabolic Syndrome | / 8卷
关键词：
Nateglinide; Rosiglitazone; GLP-1; Haemostatic factors; Inflammatory markers; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Basal Insulin NPH, Glargine and Detemir in Type 2 Diabetes: Hepatospecificity, Effects on Glucose, Lipid Metabolism, and Pancreatic Islet Alpha- and Beta-Cell Rest: A PK-PD Study
    Porcellati, Francesca
    Rossetti, Paolo
    Lucidi, Paola
    Candeloro, Paola
    Cioli, Patrizia
    Marzotti, Stefania
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    DIABETES, 2010, 59 : A10 - A10
  • [32] Effects of Ileo-Colonic Delivery of Conjugated Bile Acids on Glucose Metabolism, GLP-1, and Body Weight in Patients with Obesity and Type 2 Diabetes Mellitus-A Randomized Controlled Trial
    Manrique, Gerardo Calderon
    Davis, Judith
    Bonis, Alison N.
    Khemani, Disha
    Gedulin, Bronislava
    Vella, Adrian
    Camilleri, Michael
    Acosta, Andres
    DIABETES, 2018, 67
  • [33] The effects of sesame, canola, and sesame-canola oils on cardiometabolic markers in patients with type 2 diabetes: a triple-blind three-way randomized crossover clinical trial
    Amiri, Mojgan
    Raeisi-Dehkordi, Hamidreza
    Moghtaderi, Fatemeh
    Zimorovat, Alireza
    Mohyadini, Matin
    Salehi-Abargouei, Amin
    EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (07) : 3499 - 3516
  • [34] Effects of Non-Surgical Periodontal Treatment on Clinical Response, Serum Inflammatory Parameters, and Metabolic Control in Patients With Type 2 Diabetes: A Randomized Study
    Chen, Lei
    Luo, Gang
    Xuan, Dongying
    Wei, Bihong
    Liu, Fang
    Li, Jing
    Zhang, Jincai
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (04) : 435 - 443
  • [35] Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)
    Aroda, V. R.
    Bailey, T. S.
    Cariou, B.
    Kumar, S.
    Leiter, L. A.
    Raskin, P.
    Zacho, J.
    Andersen, T. H.
    Philis-Tsimikas, A.
    DIABETES OBESITY & METABOLISM, 2016, 18 (07): : 663 - 670
  • [36] Adherence and persistence in patients with type 2 diabetes initiating once-weekly versus once-daily injectable GLP-1 RAs in US clinical practice (STAY study)
    Polonsky, W. H.
    Arora, R.
    Faurby, M.
    Fernandes, J.
    Liebl, A.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 16 - 16
  • [37] A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
    Nauck, Michael A.
    Petrie, John R.
    Sesti, Giorgio
    Mannucci, Edoardo
    Courreges, Jean-Pierre
    Lindegaard, Marie L.
    Jensen, Christine B.
    Atkin, Stephen L.
    DIABETES CARE, 2016, 39 (02) : 231 - 241
  • [38] Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study
    Grunberger, G.
    Chang, A.
    Garcia Soria, G.
    Botros, F. T.
    Bsharat, R.
    Milicevic, Z.
    DIABETIC MEDICINE, 2012, 29 (10) : 1260 - 1267
  • [39] The effect of the GLP-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled cross over study
    Kumarathurai, P.
    Anholm, C.
    Madsbad, S.
    Moelvig, J.
    Kristiansen, O.
    Nielsen, O. W.
    Haugaard, S. B.
    Sajadieh, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 123 - 123
  • [40] Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial
    Helsted, Mads M.
    Gasbjerg, Laerke S.
    Vilsboll, Tina
    Nielsen, Casper K.
    Forman, Julie L.
    Christensen, Mikkel B.
    Knop, Filip K.
    BMJ OPEN, 2023, 13 (02):
12345